New patent for Novartis Pharms drug PROMACTA

Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis Pharms Corp and is included in two NDAs. It is available from two suppliers. There are twenty-two… The post New patent for Novartis Pharms drug PROMACTA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: